Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone

Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone


A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021.

Andrew Kelly | Reuters

Walgreens on Wednesday said it will offer its own cheaper version of the over-the-counter opioid overdose reversal spray naloxone. The drug is available online and will be in all stores at the end of the month. 

The drug store retailer aims to boost the availability of the life-saving medication in the U.S. as the nation grapples with the toll of the opioid epidemic and attempts to bring down alarmingly high drug fatality rates.

More than 645,000 people died from overdoses involving any opioid, including prescription and illicit opioids, from 1999 to 2021, according to the latest data from the Centers for Disease Control and Prevention.

Naloxone can temporarily reverse the effects of an overdose from opioids, including heroin and fentanyl, when administered in time. The drug blocks the effects of opioids on the brain, restoring normal breathing and preventing death.

Despite naloxone’s efficacy, access to the treatment “remains limited in many communities,” according to a Walgreens release. 

The company said it will sell a two-dose pack of “Walgreens Brand Naloxone” for $34.99. That’s around $10 cheaper than the over-the-counter branded drug Narcan, which became the first prescription-free version of naloxone to win Food and Drug Administration approval last year. Previously, patients needed a prescription to access naloxone.

“That was a concerted decision to really do everything we can to increase accessibility, not just in terms of quantity and availability, but also in price,” Dr. Priya Mammen, senior medical director in Walgreens’ Office of Clinical Integrity, told CNBC in an interview. 

The company said the launch of its prescription-free naloxone nasal spray comes after the FDA’s recent approval of the product. It is the generic equivalent of over-the-counter Narcan, which Walgreens currently offers in its stores.

Mammen hopes that Walgreens can help reduce the stigma associated with drug overdoses and naloxone use. 

The drug “is not just for some people. It’s a life-saving medication that can intervene on anyone at any age, anytime, and it’s something that families, individuals and communities can empower themselves by having it available and can be part of the solution,” she said. 



Source

UnitedHealth says it is cooperating with DOJ investigation into Medicare billing practices
Health

UnitedHealth says it is cooperating with DOJ investigation into Medicare billing practices

The UnitedHealth logo on a laptop arranged in New York, US, on Friday, July 7, 2023. Gabby Jones | Bloomberg | Getty Images UnitedHealth Group revealed Thursday it is facing a Justice Department investigation over its Medicare billing practices, adding to a string of setbacks for a company that owns the nation’s largest and most […]

Read More
Healthy Returns: Researchers move closer to a universal cancer vaccine
Health

Healthy Returns: Researchers move closer to a universal cancer vaccine

Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A universal cancer vaccine – what once seemed like a pipe dream – may be inching closer to becoming reality.  On […]

Read More
U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 
Health

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., speaks with Agriculture Secretary Brooke Rollins and Senator Roger Marshall (R-KS) ahead of a roundtable event as part of the “Make America Healthy Again” (MAHA) agenda, on Capitol Hill in Washington, D.C., U.S., July 15, 2025. Ken Cedeno | Reuters The Department of Health […]

Read More